| HOME >> MEDICINE >> TECHNOLOGY |
For more information visit http://www.astrazeneca-us.com.
References
(1) Tashkin, D.P., Rennard, S.I., Martin, P., Goldman, M., Silkoff, P.E. Efficacy of Budesonide/Formoterol Administered Via One Pressurized Metered- Dose Inhaler Over 6 Months in Patients with Chronic Obstructive Pulmonary Disease [poster]. CHEST, Oct. 25-30, 2008, Philadelphia. Poster #298.
(2) Tashkin, D.P., Rennard, S.I., Martin, P., Goldman, M., Silkoff, P.E. Tolerability of Budesonide and Formoterol Administered in One Pressurized Metered-Dose Inhaler Over 6 Months in Patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease [poster]. CHEST, Oct. 25-30, 2008, Philadelphia. SHINE Safety Poster.
(3) Rennard, S.I., Tashkin, D.P., McElhattan, J., Goldman, M., Silkoff, P.E. Long-term Efficacy of Budesonide/Formoterol Administered Via One Pressurized Metered-Dose Inhaler in Patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease [poster]. CHEST, Oct. 25-30, 2008, Philadelphia. Poster #303.
(4) Rennard, S.I., Tashkin, D.P., McElhattan, J., Goldman, M., Silkoff, P.E. Long-term Tolerability of Budesonide and Formoterol Administered Via One Pressurized Metered-Dose Inhaler in Patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease [poster]. CHEST, Oct. 25-30, 2008, Philadelphia. Poster #308.
(5) Nelson, H.S., Tashkin, D.P., Rennard, S.I., Martin, P., Goldman, M., Silkoff, P.E. Onset of Bronchodilation with Budesonide and Formoterol Administered in One Pressurized Metered-Dose Inhaler in Patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease [poster]. CHEST, Oct. 25- 30, 2008, Philadelphia. Poster #302.
(6
'/>"/>
| SOURCE AstraZeneca Copyright©2008 PR Newswire. All rights reserved |